Alembic Pharmaceuticals reports 35% rise in Q2 consolidated net profit

23 Oct 2020 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2020.

The company has reported 29.63% rise in its net profit of Rs 348.30 crore for the quarter under review as against net profit of Rs 268.69 crore for the same quarter in the previous year. Total income of the company increased 23.58% at Rs 1402.84 crore for Q2FY21 as compared Rs 1135.18 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 35.37% rise in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 333.37 crore for the quarter under review as against net profit of Rs 246.27 crore for the same quarter in the previous year. Total income of the company increased by 17.65% at Rs 1460.32 crore for Q2FY21 as compared Rs 1241.23 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

880.60 -19.30 (-2.14%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×